Lacombe-Duncan Ashley, Kattari Shanna K, Emrick Rebecca, Alexander Flyn, Kluger Hadas, Kattari Leo, Niedzwiecki Ashton, Scheim Ayden I, Misiolek Brayden A
School of Social Work, University of Michigan, Ann Arbor, Michigan, USA.
Women's College Hospital, Toronto, Ontario, Canada.
Int J Sex Health. 2025 Jul 31. doi: 10.1080/19317611.2025.2536252.
Transgender and gender diverse (TGD) persons are disproportionately affected by sexually transmitted infection (STI) inequities. Research predominantly focuses on HIV disparities among transfeminine persons, whereas non-HIV STIs (e.g., chlamydia) and transmasculine and nonbinary persons are overlooked. Thus, we examined barriers and facilitators to uptake of non-HIV STI testing among TGD persons, inclusive of transmasculine, transfeminine, and nonbinary persons.
This community-based explanatory sequential mixed-methods study utilized secondary quantitative data collected 2018-2019 from the Michigan Trans Health Survey (n = 528) analyzed utilizing logistic regression to test associations between social ecological hypothesized factors and non-HIV STI testing. Primary qualitative focus group data collected 2022 (n = 36 TGD participants) were analyzed using a reflexive thematic approach.
In multivariable analyses adjusting for age and race, reporting a very/somewhat inclusive primary care provider and ever experiencing sexual violence were statistically significantly positively associated with testing. Five themes were identified that illustrated the complexity of the testing process: 1) The "why" motivating testing; 2) "I've been vocal": The impact of individual agency on TGD peoples' testing practices; 3) "It's a big ordeal": Running the gauntlet of testing; 4) "Doesn't give me a hassle": Gratitude for bare minimum dignity when accessing care; and, 5) "Open, honest, and transparent": Increased testing access due to collaborative, judgment-free, and trustworthy patient-provider relationships.
Findings inform future interventions to increase STI testing among TGD populations, such as enhanced trauma-informed, intersectional, and gender-affirming STI testing, across urgent care, sexual and reproductive healthcare, and primary care. Findings call for systems-level change to promote such care to increase STI testing and advance health equity among TGD populations.
跨性别者和性别多样化(TGD)人群在性传播感染(STI)不平等方面受到的影响尤为严重。研究主要关注跨性别女性人群中的艾滋病毒差异,而其他非艾滋病毒性传播感染(如衣原体)以及跨性别男性和非二元性别者则被忽视。因此,我们研究了TGD人群(包括跨性别男性、跨性别女性和非二元性别者)接受非艾滋病毒性传播感染检测的障碍和促进因素。
这项基于社区的解释性序列混合方法研究利用了2018 - 2019年从密歇根跨性别健康调查中收集的二次定量数据(n = 528),采用逻辑回归分析来检验社会生态假设因素与非艾滋病毒性传播感染检测之间的关联。2022年收集的主要定性焦点小组数据(n = 36名TGD参与者)采用反思性主题方法进行分析。
在对年龄和种族进行调整的多变量分析中,报告有非常/ somewhat包容的初级保健提供者以及曾经历性暴力与检测在统计学上显著正相关。确定了五个主题,阐明了检测过程的复杂性:1)促使检测的“原因”;2)“我直言不讳”:个人能动性对TGD人群检测行为的影响;3)“这是一场大考验”:经历检测的重重困难;4)“不给我添麻烦”:在获得护理时对起码尊严的感激;5)“开放、诚实和透明”:由于协作、无评判和值得信赖的医患关系而增加检测机会。
研究结果为未来增加TGD人群性传播感染检测的干预措施提供了信息,例如在紧急护理、性与生殖健康护理以及初级保健中加强创伤知情、交叉性和性别肯定性的性传播感染检测。研究结果呼吁进行系统层面的变革,以促进此类护理,增加性传播感染检测,并推进TGD人群的健康公平。